Evotec SE (EVOTF) EBITDA (2009 - 2025)
Evotec SE (EVOTF) posted EBITDA of $67514.5 for Q4 2025, up 229.77% sequentially from -$52025.3 in Q3 2025, and up 121.69% YoY from $30455.0 in Q4 2024.
Evotec SE (EVOTF) EBITDA (2009 - 2025) Analysis & Trends
Evotec SE has reported EBITDA for 9 years, with the latest figure at $67514.5 in Q4 2025.
- Quarterly EBITDA rose 121.69% year-over-year to $67514.5 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $16849.1 (down 75.46% YoY) and the FY2025 annual result came in at $61927.1, up 156.42% from the prior year.
- EBITDA grew to $67514.5 in Q4 2025 per EVOTF's latest filing, from -$52025.3 in the prior quarter.
- Over five years, EBITDA peaked at $80176.3 in Q4 2021 and troughed at -$52025.3 in Q3 2025.
- A 5-year average of $17042.0 and a median of $20918.2 in 2021 frame the typical range for EBITDA.
- The sharpest annual moves came in 2023 and 2025: EBITDA slumped 882.27% in 2023, then jumped 121.69% in 2025.
- Over 5 years, EBITDA stood at $80176.3 in 2021, then slumped by 43.25% to $45503.0 in 2022, then advanced by 18.73% to $54024.0 in 2023, then plunged by 43.63% to $30455.0 in 2024, then soared by 121.69% to $67514.5 in 2025.
- According to Business Quant data, EBITDA over the past three periods registered $67514.5, -$52025.3, and $30455.0 for Q4 2025, Q3 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 67,514.52 |
| Sep 30, 2025 | -52,025.29 |
| Dec 31, 2024 | 30,454.97 |
| Sep 30, 2024 | -29,095.13 |
| Dec 31, 2023 | 54,024.02 |
| Sep 30, 2023 | 13,266.65 |
| Jun 30, 2023 | -39,514.89 |
| Dec 31, 2022 | 45,503.03 |
| Sep 30, 2022 | 13,640.94 |
| Jun 30, 2022 | -4,022.80 |
| Mar 31, 2022 | 21,169.53 |
| Dec 31, 2021 | 80,176.35 |
| Sep 30, 2021 | 20,918.20 |
| Jun 30, 2021 | 8,162.55 |
| Mar 31, 2021 | 25,457.61 |
| Dec 31, 2020 | 127,123.14 |
| Sep 30, 2020 | 21,663.16 |
| Dec 31, 2019 | 69.41 Mn |
| Sep 30, 2010 | 867.74 |
| Jun 30, 2010 | 2,315.10 |